Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
O95716
UPID:
RAB3D_HUMAN
Alternative names:
-
Alternative UPACC:
O95716
Background:
Ras-related protein Rab-3D plays a crucial role in protein transport, specifically in the process of regulated exocytosis, as suggested by similarity to other proteins in its family. This protein is part of the Rab subfamily of small GTPases, which are key regulators of intracellular membrane trafficking.
Therapeutic significance:
Understanding the role of Ras-related protein Rab-3D could open doors to potential therapeutic strategies. Its involvement in exocytosis suggests it may play a role in neurotransmitter release, insulin secretion, and other critical exocytic processes, making it a potential target for therapeutic intervention.